| | Antigen | HLA restriction |
| | Oncospermatogonal antigens |
| | MAGE-A1 | A*01, A*03, A*24, A*28, B*3701, B*53, Cw*0201, Cw*0301, Cw*1601 | | MAGE-A2 | A*0201, B*3701 | | MAGE-A3 | A*01, A*02, A*2402, B*3701, B*44, DR*11 | | MAGE-4 | A*0201 | | MAGE-A6 | A*3402, B*3701 | | MAGE-A10 | A*0201 | | MAGE-A12 | A*0201 | | MAGE-B1 | A*0201 | | MAGE-B2 | A*0201 | | BAGE | Cw*1601 | | GAGE-1 | Cw*6 | | LAGE-1 | A*0201 | | PRAME | A*24 | | NY-ESO-1 | A*02, A*31 | | DAM-6 | A*02 |
| | Melanocytic differentiation antigens |
| | Tyrosinase | A*01, A*0201, A*2402, B*44, DRβ1*0401 | | MART-1/Melan-A | A*0201, A*02, B*4501 | | Gp100 | A*0201, A*03, A*0301, A*1101, A*2402, C*0802, DRβ1*0401 | | TRP-1 | A*31 | | TRP-2 | A*31, A*33, A*0201, C*0802, A*68011 | | MC1R | A*0201 |
| | Mutated antigens |
| | MUM-1 | B*44 | | CDK4 | A*02 | | B-catenin | A*24 | | P15 | A*24 | | GnT-V | A*02 | | TPI | DRβ1*0101 | | Annexin II | DRβ1*0401 | | CDC27 | DRβ1*0401 |
| | Oncogene-derived antigens |
| | HER2/Neu | A*0201 |
|
|
